Valuation: Becton, Dickinson and Company

Market Cap 5.31TCr 1,79500Cr 4.77TCr 4.41TCr 3.99TCr 7.46TCr 5,06000Cr 7.55TCr 53TCr 21TCr 2,64800Cr 20TCr 20TCr 8,40500Cr P/E 2026 *
38.7x
P/E 2027 * 23.1x
Enterprise Value 6.9TCr 2,33100Cr 6.19TCr 5.72TCr 5.18TCr 9.69TCr 6,57200Cr 9.8TCr 68TCr 27TCr 3,43900Cr 26TCr 25TCr 10,91800Cr EV / Sales 2026 *
3.58x
EV / Sales 2027 * 3.4x
Free-Float
73.18%
Yield 2026 *
2.14%
Yield 2027 * 2.18%
1 week+2.80%
Current month+7.84%
1 month+10.00%
3 months+25.00%
6 months+33.33%
Current year+8.91%
1 week 2.12
Extreme 2.12
2.26
1 month 1.97
Extreme 1.97
2.26
Current year 1.54
Extreme 1.54
2.36
1 year 1.54
Extreme 1.54
2.36
3 years 1.54
Extreme 1.54
2.36
5 years 1.54
Extreme 1.54
2.36
10 years 1.54
Extreme 1.54
2.36
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer 56 04/12/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.80% - - 5.31TCr
-0.45%+2.12%-18.93%+10.37% 18TCr
+0.86%+2.15%-19.13%+15.77% 12TCr
+0.88%+1.88%+1.66%+35.46% 12TCr
-2.26%+18.07%-43.85%+5.76% 9.31TCr
-0.31%-4.72%-3.36%+74.94% 6.21TCr
+0.17%+1.64%+8.50%+82.24% 5.59TCr
+0.07%+0.42%+5.94%-22.27% 5.31TCr
+0.30%+1.70%-11.26%+42.01% 4.42TCr
+0.10%+3.37%-4.73%-8.71% 3.36TCr
Average +0.09%+2.27%-9.46%+26.17% 8.34TCr
Weighted average by Cap. +0.20%+2.37%-12.72%+23.86%

Financials

2026 *2027 *
Net sales 1.93TCr 65TCr 1.73TCr 1.6TCr 1.45TCr 2.71TCr 1,83700Cr 2.74TCr 19TCr 7.62TCr 96TCr 7.24TCr 7.09TCr 3,05200Cr 1.97TCr 67TCr 1.77TCr 1.64TCr 1.48TCr 2.77TCr 1,87900Cr 2.8TCr 20TCr 7.79TCr 98TCr 7.4TCr 7.25TCr 3,12100Cr
Net income 140.63Cr 4.75TCr 126.17Cr 116.65Cr 105.65Cr 197.38Cr 13TCr 199.77Cr 1.39TCr 555.53Cr 7.01TCr 527.73Cr 516.59Cr 22TCr 219.2Cr 7.41TCr 196.67Cr 181.83Cr 164.67Cr 307.65Cr 21TCr 311.37Cr 2.17TCr 865.91Cr 11TCr 822.57Cr 805.21Cr 35TCr
Net Debt 1.59TCr 54TCr 1.43TCr 1.32TCr 1.19TCr 2.23TCr 1,51300Cr 2.26TCr 16TCr 6.27TCr 79TCr 5.96TCr 5.84TCr 2,51300Cr 1.4TCr 47TCr 1.25TCr 1.16TCr 1.05TCr 1.96TCr 1,32900Cr 1.98TCr 14TCr 5.51TCr 70TCr 5.24TCr 5.12TCr 2,20700Cr
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
28/26/28 THB 2.200 0.00% 27,889
27/26/27 THB 2.200 -0.90% 52,725
26/26/26 THB 2.220 +3.74% 1,53,867
22/26/22 THB 2.140 +0.94% 19,473
21/26/21 THB 2.120 -0.93% 3,812
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
195.03USD
Average target price
195.57USD
Spread / Average Target
+0.28%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Becton, Dickinson and Company